FUNDING & OPPORTUNITIES 

The Milner Therapeutics Institute is part of the School of Biological Sciences and the School of Clinical Medicine at the University of Cambridge, and is dedicated to the conversion of ground breaking science into therapies. Based on the Cambridge Biomedical Campus, the institute is surrounded by a global therapeutic alliance of 74 SMEs, pharma companies, academic institutions and venture capital firms.

We periodically run calls that offer physical space for startup companies, as well as opportunities for funding and collaboration. Please see below for a list of our current opportunities.

Consortium Call

The Milner Therapeutics Consortium is seeking proposals for academic-industry research collaborations that can transform pioneering science into therapies by developing better models of disease and uncovering novel and biologically informed targets.

Do you have an idea for a potential pre-clinical collaborative project that would benefit from industry expertise and know-how? Our pharma partners in the Milner Therapeutics Consortium are working together with academics at the University, Babraham and Wellcome Sanger Institutes on early stage research collaborations to apply novel technologies and advanced disease models to better understand disease mechanisms, and to discover and validate new therapeutic targets.

For more details click here

Bio-Incubator Space

Are you a start-up interested in bio-incubator space?

We currently have a unique opportunity for you to be part of a vibrant Institute in a much sought after location on Cambridge Biomedical Campus. The Milner Therapeutics Institute has limited space for research intensive, R&D companies, working in an areas related to the Institute’s expertise (e.g. functional genomics, early target discovery, therapeutics). You will be working side by side with academics, entrepreneurs and industry scientists.

To discuss – contact@milner.cam.ac.uk #incubator #startup #innovation#entrepreneurship

 

Pin It on Pinterest